Annual Biomarker Congress

Event details

Date: February 18, 2020 - February 20, 2019
Website:
Location: Manchester Central Convention Complex, Petersfield, Manchester, M2 3GX, United Kingdom, Europe
About

At the 15th Annual Biomarkers Congress, over 350 attendees will be representing global pharmaceutical organizations, leading biotech and diagnostic companies as well as internationally renowned academic and healthcare institutions working in the biomarker space across multiple therapeutic areas, such as immuno-oncology, neuroscience and cardiology. The event will feature over 100 presentations, workshops, roundtables and panel discussions focusing on the key opportunities and challenges in biomarker research, from precision medicine and diagnostics through to preclinical and clinical research. The conference will feature the following interactive streams:

  • Biomarkers in drug discovery & development – therapeutic areas: oncology, immuno-oncology and immunology
  • Biomarkers in drug discovery & development – therapeutic areas: neuroscience, cardiovascular disorders and rare disease
  • Biomarkers for detection, monitoring & diagnosis
  • New biomarker technologies & data
  • Biomarkers for clinical development
  • Biomarkers for preclinical development

Interested in biomarker research? Why not check out…

biomarker-validation-lbaLBA for biomarker validation: an interview with Joel Mathews

Rafiq ThumbnailBiomarker validation and flow cytometry: an interview with Rafiq Islam

Biomarkers Spotlight2018 White Paper on Recent Issues in Bioanalysis: ‘A global bioanalytical community perspective on last decade of incurred samples reanalysis (ISR)’ (Part 1 – small molecule regulated bioanalysis, small molecule biomarkers, peptides & oligonucleotide bioanalysis)